Document is current
Any future updates will be listed below
-
Authors
Büttner, Matthias
Singer, Susanne
Hentschel, Leopold
Richter, Stephan
Hohenberger, Peter
Kasper, Bernd
Andreou, Dimosthenis
Pink, Daniel
Taylor, Kathy
Arndt, Karin
Bornhäuser, Martin
Schmitt, Jochen
Schuler, Markus K.
Eichler, Martin
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (111713)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- License Information
-
More Information
Article History
Received: 9 March 2021
Accepted: 26 June 2021
First Online: 11 July 2021
Declarations
:
: Ethics approval was obtained by the ethics committee of Technical University of Dresden (AZ: EK 1790422017) and the ethics committees of the participating centers.
: Informed consent was obtained from all individual participants included in the study.
: N/A.
: M.Bu. reports personal fees from Lilly and Takeda outside the submitted work.S.S. received lecture fees from Lilly, BMS, Boehringer-Ingelheim, and Pfizer, all outside of this work.J.S. received consulting fees from Novartis, Sanofi, A.L.K, and Lilly, all outside of this work. D.A received lecture fees from Lilly and Implantcast, all outside of this work.M.K.S. received research funding from PharmaMar and Novartis, all outside of this work. L.H. received fees from SERVIER, outside of this work.M.E., B.K., K.A., M.Bo., P.H., K.T., and S.R. declare that no conflicts of interest exist.
